VerifyRecall
Alerts
ACTIVE RECALL — CLASS IIActive recallD-0417-2025/FDA enforcement
L'oreal USA·Cosmetics·Mar 5, 2025

La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl…

What you need to know

Class II

  • What happened

    Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

  • Health risk

    The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. A known human carcinogen that can be introduced through contaminated ingredients or manufacturing processes.

  • Action required

    Stop applying or using the product. Check the UPC and lot codes below, then return it to the retailer or contact the manufacturer about a refund or replacement.

Active recall · classified by the FDANationwide (US)More cosmetics

Advertisement

Ad

Know someone who bought this?

A quick share can keep a pantry check from becoming a missed warning.

Share via WhatsApp

Match before you discard

Product identification

Source: FDA COSMETICS

Brand nameL'oreal USA
Recalling firmL'oreal USAClark, NJ, United States
UPC / barcodes
8 83140 50075 9
Lot / date codes
  • Lot #: MYX46W, Exp 04/30/2025
Distribution area
Nationwide

Nationwide in the USA

United States

Quantity affected2, 226, 801 bottles
Recall initiationFDA report date: May 21, 2025
FDA recall numberD-0417-2025

Beyond the headline

The recall, in context

L'oreal USA initiated this cosmetics recall on March 5, 2025. The FDA enforcement report states: Chemical Contamination: This recall has been initiated due to detected trace levels of benzene. The FDA report lists distribution as: Nationwide in the USA.

The FDA enforcement report describes the reason as: Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl… was made or distributed by L'oreal USA in Clark, NJ, United States. This page reflects FDA report D-0417-2025, dated May 21, 2025.

Why this is a Class II recall

Class II means the product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote. In this recall, a known human carcinogen that can be introduced through contaminated ingredients or manufacturing processes.

FDA definition

The product may cause temporary or medically reversible health consequences, or the probability of serious harm is remote.

What to do now

  1. 1

    Stop using it

    Set the product aside and do not apply it.

  2. 2

    Check the codes

    Compare the UPC and lot code against the table above.

  3. 3

    Return or discard

    Contact the retailer or recalling firm about a refund, and dispose of the product safely.

Consumer safety guide

Benzene contamination

Possible health effects

Benzene is a known human carcinogen. Long-term exposure is associated with blood disorders and cancer. A recall is a precautionary step to reduce exposure.

When symptoms may appear

Health effects are generally associated with repeated or long-term exposure rather than a single incubation period.

Higher-risk groups

People who use the affected product frequently, pregnant people, children and people with existing blood disorders should be especially cautious.

What to do now

  1. 1Stop using the affected cosmetic or personal-care product immediately.
  2. 2Keep the package and contact the retailer or manufacturer about a refund or replacement; do not use it as a substitute.
  3. 3If you have concerns about exposure or symptoms, speak with a healthcare professional.

Benzene is a known human carcinogen; this information is not a personal exposure assessment.

This is general consumer safety information, not medical advice or a diagnosis. Follow the official recall notice and contact a healthcare professional if you have concerns about exposure or symptoms.

Frequently asked

Questions about this recall

What is the La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl… recall?

L'oreal USA recalled La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl… in an FDA Class II enforcement action reported as D-0417-2025. Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.

What should I do if I bought this product?

Stop applying or using the product. Check the UPC and lot codes below, then return it to the retailer or contact the manufacturer about a refund or replacement. Stop using the affected cosmetic or personal-care product immediately. Keep the package and contact the retailer or manufacturer about a refund or replacement; do not use it as a substitute. If you have concerns about exposure or symptoms, speak with a healthcare professional.

Is the L'oreal USA recall still active?

Yes. As of the latest FDA enforcement report, this recall is listed as ongoing. Check the official source record for the most current status before making a decision.

Where can I verify this recall?

This page is normalized from the openFDA enforcement record D-0417-2025. You can verify it directly using the official source link on this page. VerifyRecall updates its index from public FDA enforcement data and does not replace advice from the FDA, the recalling firm or a healthcare professional.

Verify before you act.

VerifyRecall is independent and not affiliated with the FDA. Always confirm the latest status on the official source record.

Official source

Brand history

More recalls by L'oreal USA

View brand
Class II·

L'oreal USA

La Roche-posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl…

CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the…

Nationwide (US)Cosmetics
Class II·

L'oreal USA

La Roche-posay Laboratoire Dermatologique Effaclar Dermatological Acne System, 3 Step Acne…

CGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the…

Nationwide (US)Cosmetics

Related alerts

Recent Benzene recalls

All alerts
Class II·

Owen Biosciences INC.

Fhf Farmhouse Fresh, Midnight Clearing, Night Lotion, 2.5% Benzoyl Peroxide Acne Treatment, Otc…

Chemical contamination: Presence of benzene

Nationwide (US)Cosmetics
Class II·

Owen Biosciences INC.

Hydropeptide Clear Alliance Serum, 2.5% Benzoyl Peroxide, A)1 FL Oz/30ml

Chemical contamination: Presence of benzene

Nationwide (US)Cosmetics

Record last synced from official openFDA enforcement data on November 14, 2026. Source record: official FDA notice.